Ultragenyx Pharmaceutical's IPO

Ultragenyx Pharmaceutical raised a round of funding on January 31, 2014. Investors include Public.

Ultragenyx Pharmaceutical is a developmental stage biotechnology company committed to bringing life-enhancing therapeutics for patients with rare and ultra-rare genetic diseases, also known as orphan …

Articles about Ultragenyx Pharmaceutical's IPO: